Earnings out of Amgen Inc. (NASDAQ: AMGN) appear to be strong enough to defy any notions that the big osteoporosis news would render this particular earnings report immaterial. The biotech giant just posted adjusted…
After today’s close, we’ll be getting earnings out of biotech giant Amgen Inc. (NASDAQ: AMGN). It’s amazing how the company’s strong osteoporosis data has suddenly gotten the company out of the gutter and suddenly…
This weekend and this last week has created a lot of buzz around the mighty medical robotics player Intuitive Surgical Inc. (NASDAQ: ISRG). For starters, it did beat earnings and it raised 2008 guidance. …
Apparently the IPO filing hiatus isn’t entirely a dead end story. A company called AutoGenomics, Inc. has filed a registration statement for a proposed initial public offering. It has applied for the ticker "AGMX"…
Vital Signs Inc. (NASDAQ: VITL) is going to gap way up this morning. The company is being acquired by General Electric Co. for $860 million in cash, which comes to $74.50 per share. Vital…
Genentech Inc. (NYSE: DNA) is running into some issues over the merger with Roche at $89.00 per share. Wall Street DOES expect this merger to close with Genentech becoming a subsidiary again rather than…
State Street Corporation (NYSE: STT) has announced that its State Street Global Advisors unit is launching 10 new SPDR exchange-traded funds, which are supposed to begin trading on the American Stock Exchange today. SPDR(R)…
Merck & Co. (NYSE: MRK) posted earnings that look pretty good on the surface. The problem is that the surface is about the only thing that looked appealing for the drug giant today. Merck…
ImClone Systems Incorporated (NASDAQ: IMCL) has just announced that ERBITUX(R) has received marketing authorization in Japan for use in treating patients with advanced or metastatic colorectal cancer (mCRC). This approval will allow the use…
Genentech Inc. (NYSE: DNA) is initially looking like a severe disappointment to those who thought Cramer’s call last week was the right one. The largest biotech in the U.S. posted $0.82 EPS on $3.23…
Genentech Inc. (NYSE: DNA) is set to report earnings after the close of trading today. The largest biotech in the U.S. is expected to post $0.86 EPS on $3.23 Billion in revenues according to…
We have run a full feature story over at BioHealthInvestor.com after reading a study that came off the Mayo Clinic site. The study showed that a combination of fish oil and red rice yeast…
We saw another exciting week full of news for key developments in drug stocks, biotech stocks, medical device stocks, and other companies involved in various aspects of health care and medicine. Below are some…
ZONARE MEDICAL SYSTEMS, INC. has filed for an initial public offering to sell up to $86.25 million as the nominal securities amount. The company has applied to take on the stock ticker of "ZONE"…
A company called Alimera Sciences, Inc. has filed for an initial public offering to sell up to $75 million as the nominal securities amount. The company noted that all shares will be sold by…